Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

[Outcomes of preoperative chemoradiotherapy for rectal cancer with invasion to the adjacent organs].

Sato H, Koide Y, Shiota M, Endo T, Matsuoka S, Hatta K, Mizuno M, Maeda K, Toyama K.

Gan To Kagaku Ryoho. 2013 Nov;40(12):1968-70. Japanese.

PMID:
24393982
2.

[Results of preoperative chemoradiotherapy for T4 rectal cancer].

Sato H, Maeda K, Masumori K, Koide Y, Noro T, Honda K, Shiota M, Matsuoka S, Toyama K.

Gan To Kagaku Ryoho. 2011 Nov;38(12):2232-4. Japanese.

PMID:
22202339
3.

[Our experiences of preoperative chemoradiotherapy for rectal cancer with invasion to adjacent organs].

Sato H, Maeda K, Hanai T, Koide Y, Matsuoka H, Katsuno H, Agata T, Noro T, Honda K, Shiota M, Ozeki S, Hatta K.

Gan To Kagaku Ryoho. 2009 Nov;36(12):2143-5. Japanese.

PMID:
20037350
4.

[Our experiences of preoperative chemo-radiotherapy for T4 primary rectal cancer].

Sato H, Maeda K, Hanai T, Koide Y, Aoyama H, Matsuoka H, Katsuno H, Funahashi M, Agata T, Noro T, Honda K, Shiota M.

Gan To Kagaku Ryoho. 2008 Nov;35(12):2018-20. Japanese.

PMID:
19106509
5.

High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): a phase I trial.

Vestermark LW, Jensen HA, Pfeiffer P.

Acta Oncol. 2012 Mar;51(3):311-7. doi: 10.3109/0284186X.2011.652740. Epub 2012 Jan 17.

PMID:
22248062
6.

Extensive surgery after high-dose preoperative chemoradiotherapy for locally advanced recurrent rectal cancer.

Rödel C, Grabenbauer GG, Matzel KE, Schick C, Fietkau R, Papadopoulos T, Martus P, Hohenberger W, Sauer R.

Dis Colon Rectum. 2000 Mar;43(3):312-9.

PMID:
10733111
7.

[Preoperative chemoradiotherapy with S-1 for advanced low rectal cancer].

Kitani K, Okajima K, Sato K, Isono S, Kimura H, Ikeda M, Inoue K, Iwama M, Tsujie M, Nakayama T, Fujiwara Y, Murata M, Yukawa M, Ota Y, Inoue M.

Gan To Kagaku Ryoho. 2011 Nov;38(12):2122-4. Japanese.

PMID:
22202303
8.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM)..

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.

PMID:
16414206
9.

Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study.

Uzcudun AE, Batlle JF, Velasco JC, Sánchez Santos ME, Carpeño Jde C, Grande AG, Juberías AM, Piñeiro EH, Olivar LM, García AG.

Dis Colon Rectum. 2002 Oct;45(10):1349-58.

PMID:
12394434
10.

Late patient-reported toxicity after preoperative radiotherapy or chemoradiotherapy in nonresectable rectal cancer: results from a randomized Phase III study.

Brændengen M, Tveit KM, Bruheim K, Cvancarova M, Berglund Å, Glimelius B.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1017-24. doi: 10.1016/j.ijrobp.2010.07.007. Epub 2010 Oct 6.

PMID:
20932687
11.

Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.

Tural D, Ozturk M, Selcukbiricik F, Yildiz O, Elicin O, Turna H, Guney S, Ozguroglu M.

J BUON. 2013 Apr-Jun;18(2):385-90.

PMID:
23818350
12.

Preoperative versus postoperative chemoradiotherapy for rectal cancer.

Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R; German Rectal Cancer Study Group..

N Engl J Med. 2004 Oct 21;351(17):1731-40.

13.

Complications after sphincter-saving resection in rectal cancer patients according to whether chemoradiotherapy is performed before or after surgery.

Kim CW, Kim JH, Yu CS, Shin US, Park JS, Jung KY, Kim TW, Yoon SN, Lim SB, Kim JC.

Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):156-63. doi: 10.1016/j.ijrobp.2009.07.1684. Epub 2010 Jan 26.

PMID:
20106604
14.

Clinical significance of pre- to post-chemoradiotherapy s-CEA reduction ratio in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection.

Kim CW, Yu CS, Yang SS, Kim KH, Yoon YS, Yoon SN, Lim SB, Kim JC.

Ann Surg Oncol. 2011 Nov;18(12):3271-7. doi: 10.1245/s10434-011-1740-1. Epub 2011 May 3.

PMID:
21537868
15.

Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer.

Kim DY, Jung KH, Kim TH, Kim DW, Chang HJ, Jeong JY, Kim YH, Son SH, Yun T, Hong CW, Sohn DK, Lim SB, Choi HS, Jeong SY, Park JG.

Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):378-84. Epub 2006 Nov 9.

PMID:
17097835
16.

Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.

Lim SB, Choi HS, Jeong SY, Kim DY, Jung KH, Hong YS, Chang HJ, Park JG.

Ann Surg. 2008 Aug;248(2):243-51. doi: 10.1097/SLA.0b013e31817fc2a0.

PMID:
18650634
17.

Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer.

Park JH, Yoon SM, Yu CS, Kim JH, Kim TW, Kim JC.

Cancer. 2011 Aug 15;117(16):3703-12. doi: 10.1002/cncr.25943. Epub 2011 Feb 15.

18.

Preoperative versus postoperative chemoradiotherapy in stage T3, N0 rectal cancer.

Tural D, Selcukbiricik F, Yıldız Ö, Elcin O, Erdamar S, Güney S, Demireli F, Büyükünal E, Serdengeçti S.

Int J Clin Oncol. 2014 Oct;19(5):889-96. doi: 10.1007/s10147-013-0636-4. Epub 2013 Nov 12.

PMID:
24218281
19.

Oncologic outcome after preoperative chemoradiotherapy in patients with pathologic T0 (ypT0) rectal cancer.

Jang TY, Yu CS, Yoon YS, Lim SB, Hong SM, Kim TW, Kim JH, Kim JC.

Dis Colon Rectum. 2012 Oct;55(10):1024-31. doi: 10.1097/DCR.0b013e3182644334.

PMID:
22965400
20.

Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.

Chan AK, Wong A, Jenken D, Heine J, Buie D, Johnson D.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):665-77.

PMID:
15708244

Supplemental Content

Support Center